Impax Laboratories Inc. and Amneal Pharmaceuticals LLC are close to agreement on a merger that would create the nation’s fifth-largest generic-drug company by revenue, according to people familiar with the matter.
NYS Entity Status
NYS Filing Date
APRIL 21, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2014 - ADVANCED PHARMACEUTICAL STRATEGIES LLC
Around the Web
- Impax Laboratories and Amneal Pharmaceuticals Near Merger Agreement
Monday Oct 16, 2017
- Trump’s Tough Talk on North Korea Puts Japan’s Leader in Delicate Spot
By JONATHAN SOBLE - Friday Aug 11, 2017
North Korea’s accelerating military advances — and President Trump’s volatile response — could complicate Japan’s close alliance with the United States.
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]
- The Strange Case of Martin Shkreli Is Wrapping Up
By STEPHANIE CLIFFORD - Wednesday Jul 26, 2017
An unusual trial has featured victims who actually made money and defense lawyers who paint their client as an erratic misfit and want more victims to testify.
- The Pop-Up Employer: Build a Team, Do the Job, Say Goodbye
By NOAM SCHEIBER - Wednesday Jul 12, 2017
“Flash organizations,” modeled on filmmaking, find their way into fields like software and pharmaceuticals, assembling freelancers and then disbanding.